12 Best IQVIA Patient Services Alternatives & Competitors (2026)

IQVIA offers a broad suite of real-world data, analytics and technology solutions used by pharma and life sciences companies for clinical research, commercial targeting and provider insights. Its strength lies in massive claims and prescription datasets plus consulting services, giving it wider global coverage than H1 in some therapeutic areas. However, IQVIA tends to be more expensive and less focused on unified MDM or rapid roster automation for health plans compared with H1's specialized provider and site universes.

Azure Health Data Services offers FHIR and DICOM APIs with compliance tooling for healthcare workloads. It provides scalable storage and analytics. Versus Segmed it supplies no curated imaging datasets, requiring customers to ingest and annotate their own data before AI development can begin.

ConnectiveRx delivers copay assistance and hub services with strong emphasis on automated eligibility and broad retail-pharmacy connectivity. It supports specialty brands through integrated prior-auth workflows and real-time reporting. Compared with Medmonk, it offers similar point-of-sale speed but may provide more flexible modular pricing for mid-sized launches while maintaining comparable U.S. network coverage.

Flywheel provides an enterprise imaging data platform that orchestrates curation, de-identification, and machine-learning workflows across radiology and pathology. Strengths include on-prem/cloud deployment flexibility and strong audit trails for clinical trials. Compared with Segmed, Flywheel offers deeper workflow tooling but generally smaller pre-curated regulatory-grade cohorts and less emphasis on multi-manufacturer longitudinal studies for immediate FDA validation use cases.

ConnectiveRx delivers copay assistance and hub services with strong emphasis on automated eligibility and broad retail-pharmacy connectivity. It supports specialty brands through integrated prior-auth workflows and real-time reporting. Compared with Medmonk, it offers similar point-of-sale speed but may provide more flexible modular pricing for mid-sized launches while maintaining comparable U.S. network coverage.

Philips HealthSuite aggregates imaging and patient-generated data across its hardware ecosystem with built-in analytics. Strengths include seamless modality integration. Against Segmed it is more hardware-tied, offers fewer third-party manufacturer studies, and targets hospital networks rather than external AI developers seeking broad de-identified research datasets.

Flywheel provides an enterprise imaging data platform that orchestrates curation, de-identification, and machine-learning workflows across radiology and pathology. Strengths include on-prem/cloud deployment flexibility and strong audit trails for clinical trials. Compared with Segmed, Flywheel offers deeper workflow tooling but generally smaller pre-curated regulatory-grade cohorts and less emphasis on multi-manufacturer longitudinal studies for immediate FDA validation use cases.

Doximity is the largest professional network for US physicians and offers digital marketing, recruitment and telehealth tools. Life sciences teams sometimes use its verified HCP profiles for outreach, yet it lacks H1's structured clinical trial site data, performance benchmarks and MDM capabilities. Doximity is generally lower cost for basic access but not positioned as an enterprise data platform.

Veeva provides cloud software for life sciences including CRM, clinical operations and data management platforms that many pharma teams already use. Its Vault and Network products help with HCP engagement and trial workflows, offering tighter integration with existing Veeva stacks than H1. While Veeva has strong commercial tools, it relies more on customer-supplied data and offers less standalone real-world provider intelligence than H1's pre-built universes and streams.

TrialCard specializes in copay cards, voucher programs, and patient-support hubs with rapid pharmacy adjudication. Its platform emphasizes quick enrollment and adherence tracking for specialty products. Versus Medmonk, TrialCard often competes on cost-effectiveness and customizable program design, though it may trail in rare-disease infusion-center depth and long-term brand-retention benchmarks.

Komodo Health builds software and real-world data platforms that map patient journeys and HCP influence using claims and encounter data. It excels at longitudinal patient insights and rare disease tracking, areas where H1 is lighter. Komodo's pricing is also enterprise-oriented but its focus is narrower on patient-centric analytics rather than H1's combined site selection, KOL identification and health-plan roster tools.